Androgen receptor (AR) plays a pivotal role in prostate cancer development and progression, by mediating transcription of pro-mitotic genes, including UBE2C and cyclin D, resulting in prostate cancer cell proliferation (Xu et al, 2006; Wang et al, 2009). Here, UBE2C is linked to prostate carcinoma.